Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

KBP Biosciences discloses novel mineralocorticoid receptor antagonists

Oct. 17, 2012

FDA accepts Serada NDA for filing

Oct. 16, 2012

Teijin Pharma presents novel CaSR antagonists with promising in vivo activity

Oct. 16, 2012

Novel GPR119 receptor agonists prepared by Boehringer Ingelheim and Neurocrine Biosciences

Oct. 15, 2012

Roche synthesizes new HSL inhibitors

Oct. 15, 2012

Zafgen presents novel MetAP 2 inhibitors for obesity

Oct. 11, 2012

Significant reduction of HbA1c seen with VRS-859 in clinical trial

Oct. 11, 2012

Phase I and II data presented for semaglutide

Oct. 11, 2012

Ajinomoto to study nateglinide in combination with DPP IV inhibitor

Oct. 10, 2012

European Commission approves Bayer Healthcare's Flexyess

Oct. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...